Oct 29, 2021 08:00 AM

Honz Pharmaceutical Co.,Ltd. Posted 41.1 Million Yuan Net Loss in First Three Quarters of 2021

Honz Pharmaceutical Co.,Ltd. (康芝药业股份有限公司) (300086.SZ) reported a net loss of 41.1 million yuan in the first three quarters of 2021, reversing a net profit of 7.2 million yuan for the same period in the previous year.

Meanwhile, the company posted 586.1 million yuan in revenue, down 7.2% year-on-year.

At the end of the reporting period, it had 2.4 billion yuan in total assets and 895.7 million yuan in total liabilities, with a liability-to-asset ratio of 37.4%.

This article was automatically produced by Caixin Automation on Nov. 3, 2021.

Download our app to receive breaking news alerts and read the news on the go.

Follow the Chinese markets in real time with Caixin Global’s new stock database.

Share this article
Open WeChat and scan the QR code
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription